newdrugapprovals.org
Sprout Pharmaceuticals Appeals FDA Decision on NDA for Flibanserin to Treat Hypoactive Sexual Desire Disorder in Premenopausal Women
Flibanserin, girosa 167933-07-5 cas no 147359-76-0 (monoHCl) Flibanserin, BIMT-17-BS, BIMT-17 1 – [2 – [4 – [3 – (Trifluoromethyl) phenyl] piperazin-1-yl] ethyl] -2,3-dihydr…